Sandy Spring Bank’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.41K Hold
1,000
﹤0.01% 963
2024
Q4
$4.65K Hold
1,000
﹤0.01% 980
2024
Q3
$6.94K Hold
1,000
﹤0.01% 918
2024
Q2
$7.8K Hold
1,000
﹤0.01% 913
2024
Q1
$7.1K Sell
1,000
-200
-17% -$1.32K ﹤0.01% 908
2023
Q4
$8.04K Buy
1,200
+100
+9% +$563 ﹤0.01% 854
2023
Q3
$6.19K Buy
+1,100
New +$7.33K ﹤0.01% 898

Other funds holding GDRX

Sandy Spring Bank's GDRX Position: Q1 2025 in Review

Sandy Spring Bank held its GoodRx Holdings (GDRX) position steady in Q1 2025 at 1,000 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Sandy Spring Bank first reported a position in GDRX in Q3 2023 and has held it in 7 quarters since. The position peaked at $8.04K in Q4 2023. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Sandy Spring Bank held 1,000 shares of GoodRx Holdings worth $4.41K as of Q1 2025.
  • Sandy Spring Bank left its GoodRx Holdings share count unchanged in Q1 2025.
  • GoodRx Holdings made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #963 holding.
  • Sandy Spring Bank first reported a position in GoodRx Holdings in Q3 2023 and has held it in 7 quarters since.
  • Sandy Spring Bank's GoodRx Holdings position peaked at $8.04K in Q4 2023.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.